檢索結果 - Jhudit Pérez‐Escuredo

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Monocarboxylate transporters in the brain and in cancer

    Monocarboxylate transporters in the brain and in cancer 由 Jhudit Pérez‐Escuredo, Vincent F. Van Hée, Martina Sboarina, Jorge Falces, Valéry L. Payen, Luc Pellerin, Pierre Sonveaux

    出版 2016
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration

    Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration 由 Christophe J. De Saedeleer, Paolo E. Porporato, Tamara Copetti, Jhudit Pérez‐Escuredo, Valéry L. Payen, Lucie Brisson, Olivier Féron, Pierre Sonveaux

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Lactate promotes glutamine uptake and metabolism in oxidative cancer cells

    Lactate promotes glutamine uptake and metabolism in oxidative cancer cells 由 Jhudit Pérez‐Escuredo, Rajesh K. Dadhich, Suveera Dhup, Andrea Cacace, Vincent F. Van Hée, Christophe J. De Saedeleer, Martina Sboarina, Fabien Rodriguez, Marie‐Joséphine Fontenille, Lucie Brisson, Paolo E. Porporato, Pierre Sonveaux

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    A Mitochondrial Switch Promotes Tumor Metastasis

    A Mitochondrial Switch Promotes Tumor Metastasis 由 Paolo E. Porporato, Valéry L. Payen, Jhudit Pérez‐Escuredo, Christophe J. De Saedeleer, Pierre Danhier, Tamara Copetti, Suveera Dhup, Morgane Tardy, Thibaut Vazeille, Caroline Bouzin, Olivier Féron, Carine Michiels, Bernard Gallez, Pierre Sonveaux

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study

    Neoadjuvant letrozole and palbociclib in patients with HR-positive/HER2-negative early breast cancer and Oncotype DX Recurrence Score ≥18: DxCARTES study 由 Ángel Guerrero‐Zotano, J. M. Perez-Garcia, Manuel Ruíz‐Borrego, Begoña Bermejo, Miguel Gil‐Gil, J. de la Haba, E. Alba Conejo, Vanesa Quiroga, Vicente Carañana, Ander Urruticoechea, Selena Morales, Meritxell Bellet, Ángela Antón, María Fernández-Abad, Pedro Sánchez‐Rovira, Laura Calabuig, Jhudit Pérez‐Escuredo, M Sampayo-Cordero, Javier Cortés, A Llombart-Cussac

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial

    Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial 由 Marta Vaz Batista, José Manuel Pérez-García, Patricia Cortez, Laia Garrigós, María Fernández-Abad, María Gión, A Martínez-Bueno, Cristina Saavedra, Iris Teruel, Adela Fernández-Ortega, Sònia Servitja, Manuel Ruíz‐Borrego, Juan de la Haba-Rodríguez, Griselda Martrat, Jhudit Pérez‐Escuredo, Daniel Alcalá-López, Miguel Sampayo-Cordero, Sofía Braga, Javier Cortés, A Llombart-Cussac

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: the OPHELIA phase 2 study

    Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: the OPHELIA phase 2 study 由 José E. Alés‐Martínez, Judith Balmañà, Pedro Sánchez‐Rovira, F.J. Salvador Bofill, José Á. García-Sáenz, Isabel Pimentel, Serafín Morales, María Fernández-Abad, A. Martinez, Neus Ferrer, Pilar Zamora, Begoña Bermejo, Tamara Díaz-Redondo, María Helena López-Ceballos, María Galán, Jhudit Pérez‐Escuredo, Laura Calabuig, Miguel Sampayo, José Manuel Pérez-García, Javier Cortés, Antonio Llombart‐Cussac

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: